These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 18508833

  • 1. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia.
    Bruns AH, Oosterheert JJ, Hak E, Hoepelman AI.
    Eur Respir J; 2008 Sep; 32(3):726-32. PubMed ID: 18508833
    [Abstract] [Full Text] [Related]

  • 2. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
    Justo D, Lachmi S, Saar N, Joffe E, Atzmony L, Mashav N, Henis O, Sade B, Chundadze T, Steinvil A, Paran Y.
    Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
    [Abstract] [Full Text] [Related]

  • 3. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B, Pasić S, Marković M, Veljković D, Milicić M.
    Srp Arh Celok Lek; 2001 Sep; 129 Suppl 1():17-22. PubMed ID: 15637985
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course.
    Coelho L, Póvoa P, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H.
    Crit Care; 2007 Sep; 11(4):R92. PubMed ID: 17723153
    [Abstract] [Full Text] [Related]

  • 5. C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
    Chalmers JD, Singanayagam A, Hill AT.
    Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306
    [Abstract] [Full Text] [Related]

  • 6. Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia.
    Igonin AA, Armstrong VW, Shipkova M, Lazareva NB, Kukes VG, Oellerich M.
    Clin Biochem; 2004 Mar; 37(3):204-9. PubMed ID: 14972642
    [Abstract] [Full Text] [Related]

  • 7. Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia.
    Hohenthal U, Hurme S, Helenius H, Heiro M, Meurman O, Nikoskelainen J, Kotilainen P.
    Clin Microbiol Infect; 2009 Nov; 15(11):1026-32. PubMed ID: 19548923
    [Abstract] [Full Text] [Related]

  • 8. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia.
    Lisboa T, Seligman R, Diaz E, Rodriguez A, Teixeira PJ, Rello J.
    Crit Care Med; 2008 Jan; 36(1):166-71. PubMed ID: 18007271
    [Abstract] [Full Text] [Related]

  • 9. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.
    Lee JH, Kim J, Kim K, Jo YH, Rhee J, Kim TY, Na SH, Hwang SS.
    J Crit Care; 2011 Jun; 26(3):287-94. PubMed ID: 21129911
    [Abstract] [Full Text] [Related]

  • 10. Serum hydrogen sulfide as a novel marker predicting bacterial involvement in patients with community-acquired lower respiratory tract infections.
    Chen YH, Yao WZ, Gao JZ, Geng B, Wang PP, Tang CS.
    Respirology; 2009 Jul; 14(5):746-52. PubMed ID: 19659653
    [Abstract] [Full Text] [Related]

  • 11. Impact of serum C-reactive protein measurements in the first 2 days on the 30-day mortality in hospitalized patients with severe community-acquired pneumonia: a cohort study.
    Nseir W, Farah R, Mograbi J, Makhoul N.
    J Crit Care; 2013 Jun; 28(3):291-5. PubMed ID: 23159134
    [Abstract] [Full Text] [Related]

  • 12. Markers of treatment failure in hospitalised community acquired pneumonia.
    Menéndez R, Cavalcanti M, Reyes S, Mensa J, Martinez R, Marcos MA, Filella X, Niederman M, Torres A.
    Thorax; 2008 May; 63(5):447-52. PubMed ID: 18245147
    [Abstract] [Full Text] [Related]

  • 13. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
    Hedlund J.
    Scand J Infect Dis Suppl; 1995 May; 97():1-60. PubMed ID: 8584866
    [Abstract] [Full Text] [Related]

  • 14. Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia.
    Agapakis DI, Tsantilas D, Psarris P, Massa EV, Kotsaftis P, Tziomalos K, Hatzitolios AI.
    Respirology; 2010 Jul; 15(5):796-803. PubMed ID: 20497384
    [Abstract] [Full Text] [Related]

  • 15. C-reactive protein for discriminating treatment failure from slow responding pneumonia.
    Ruiz-González A, Falguera M, Porcel JM, Martínez-Alonso M, Cabezas P, Geijo P, Boixeda R, Dueñas C, Armengou A, Capdevila JA, Serrano R.
    Eur J Intern Med; 2010 Dec; 21(6):548-52. PubMed ID: 21111942
    [Abstract] [Full Text] [Related]

  • 16. Value of rapid aetiological diagnosis in optimization of antimicrobial treatment in bacterial community acquired pneumonia.
    Mareković I, Plecko V, Boras Z, Pavlović L, Budimir A, Bosnjak Z, Puretić H, Zele-Starcević L, Kalenić S.
    Coll Antropol; 2012 Jun; 36(2):401-8. PubMed ID: 22856222
    [Abstract] [Full Text] [Related]

  • 17. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.
    Thiem U, Niklaus D, Sehlhoff B, Stückle C, Heppner HJ, Endres HG, Pientka L.
    Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453
    [Abstract] [Full Text] [Related]

  • 18. C-reactive protein levels and decrease of albumin levels in hospitalized elderly patients with community-acquired pneumonia.
    Harimurti K, Setiati S.
    Acta Med Indones; 2007 Nov; 39(1):13-8. PubMed ID: 17297204
    [Abstract] [Full Text] [Related]

  • 19. Predictive value of serial measurements of sTREM-1 in the treatment response of patients with community-acquired pneumonia.
    Chao WC, Wang CH, Chan MC, Chow KC, Hsu JY, Wu CL.
    J Formos Med Assoc; 2007 Mar; 106(3):187-95. PubMed ID: 17389162
    [Abstract] [Full Text] [Related]

  • 20. Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients.
    Kutz A, Grolimund E, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P, ProHOSP Study Group.
    BMC Anesthesiol; 2014 Mar; 14():102. PubMed ID: 25419180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.